Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by Ohlbe – France, 2020-04-20 10:11 (319 d 02:19 ago) – Posting: # 21337
Views: 830

Dear Silvia,

» Could the Clinical step of a BE study (screening, recruiting, administration of formulations and blood samples extractions) be carried out maintaining the HV at their own homes (always with a nurse at all times and a medical doctor visiting all the volunteers, etc etc)?

Besides what you already mention (certification of clinical centres), I see several hurdles and I don't think what you propose would be feasible/acceptable for ethics committees and authorities:
Sorry but I think all we can do is be patient...

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,366 posts in 4,462 threads, 1,493 registered users;
online 15 (0 registered, 15 guests [including 3 identified bots]).
Forum time: Friday 11:31 CET (Europe/Vienna)

The statistician has no magic touch by which
he may come in at the stage of tabulation
and make something of nothing.    W. Edwards Deming

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5